2025-04-08 18:19:51
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Mangalam Drugs and Organics Ltd Q3FY22 net profit drops to Rs. 4.02 crores
Posted On : 2022-02-04 19:08:02( TIMEZONE : IST )
Mangalam Drugs And Organics Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 101.8784 crores during the period ended December 31, 2021 as compared to Rs. 123.0233 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 4.0222 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 4.5281 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 2.54 for the period ended December 31, 2021 as compared to Rs. 2.86 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 101.8784 crs | ₹123.0233 crs |  -17.19% |
| Net Profit | ₹4.0222 crs | ₹4.5281 crs | -11.17% |
| EPS | ₹2.54 | ₹2.86 | -11.19% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 101.8784 crores during the period ended December 31, 2021 as compared to Rs.89.9551 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.4.0222 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.6.4342 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.2.54 for the period ended December 31, 2021 as compared to Rs.4.07 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 101.8784 crs | ₹89.9551 crs |  13.25% |
| Net Profit | ₹4.0222 crs | ₹6.4342 crs | -37.49% |
| EPS | ₹2.54 | ₹4.07 | -37.59% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.330.2024 crores during the 9 Months period ended December 31, 2021 as compared to Rs.291.9604 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.12.9660 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.25.8167 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.8.19 for the 9 Months period ended December 31, 2021 as compared to Rs.16.31 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹330.2024 crs | ₹291.9604 crs | 13.10% |
| Net Profit | ₹12.9660 crs | ₹25.8167 crs | -49.78% |
| EPS | ₹8.19 | ₹16.31 | -49.79% |
Shares of Mangalam Drugs And Organics Limited was last trading in BSE at Rs. 132.65 as compared to the previous close of Rs. 135.70. The total number of shares traded during the day was 2334 in over 126 trades.
The stock hit an intraday high of Rs. 144.95 and intraday low of 131.90. The net turnover during the day was Rs. 314014.00.
